Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Assembly committee hears AB 260 to protect medication abortion access, removes provider names from labels
Summary
AB 260 would shield California reproductive-health providers and pharmacies that legally dispense mifepristone from disciplinary action, require continued health-plan coverage and expand telehealth access; supporters said the bill responds to federal threats while opponents raised safety concerns about medication abortions.
Majority Leader Aguirre Curry introduced AB 260 to the Assembly Business and Professions Committee as a bill aimed at protecting access to medication abortion in California, including the drug mifepristone, and at shielding health-care providers from out‑of‑state enforcement or federal actions.
The measure would bar disciplinary action against clinicians, pharmacies, clinics and hospitals that lawfully dispense medication abortion; require health plans to continue covering medication abortion; permit removal of prescribing clinicians’ names from medication‑labeling where that is legally possible; and expand telehealth access for medication abortion services. Supporters framed the bill as a response to recent, heightened legal and enforcement risks following the Dobbs decision and recent federal reviews of abortion‑related approvals.
Supporters who testified included Angela…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
